Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,076 | -3,545 | -18,851 | -13,476 | -8,953 |
| Depreciation Amortization | 2 | 1 | 4 | 3 | 2 |
| Accounts payable and accrued liabilities | 808 | 46 | 1,322 | -483 | -680 |
| Other Working Capital | 794 | 149 | 3,699 | 1,094 | 144 |
| Other Operating Activity | -371 | 157 | -314 | 1,259 | 1,259 |
| Operating Cash Flow | $-4,843 | $-3,192 | $-14,140 | $-11,604 | $-8,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -4 | -2 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-4 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,980 | 3,546 | 5,279 | 2,828 | 2,695 |
| Other Financing Activity | -194 | -88 | -642 | -368 | -244 |
| Financing Cash Flow | $5,785 | $3,459 | $4,637 | $2,460 | $2,451 |
| Beginning Cash Position | 549 | 549 | 10,055 | 10,055 | 10,055 |
| End Cash Position | 1,492 | 815 | 549 | 910 | 4,279 |
| Net Cash Flow | $943 | $267 | $-9,507 | $-9,146 | $-5,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,843 | -3,192 | -14,140 | -11,604 | -8,227 |
| Capital Expenditure | N/A | N/A | -4 | -2 | N/A |
| Free Cash Flow | -4,843 | -3,192 | -14,144 | -11,605 | -8,227 |